Metastatic FAP-Positive Solid Tumors: [177Lu]Lu-OncoFAP-23

We are testing a new radioactive treatment for patients with metastatic FAP-positive solid tumors. The study looks at its safety and early signs of effectiveness, both alone and with another therapy.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Fondazione IRCCS Istituto Nazionale Dei Tumori
Diagnostic Imaging and Radiotherapy/Nuclear Medicine
Milan, Italy
Istituto Europeo Di Oncologia S.r.l.
Divisione di Sviluppo di Nuovi Farmaci per Terapie Innovative
Opera, Italy
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Medicina Nucleare
Soccavo, Italy

Sponsor: Philogen S.p.A.
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.